4D Molecular Therapeutics Overview4D Molecular Therapeutics Net Income
Profitability analysis for FDMT.
Quarterly Net Income
-$68.76M
↓ 43.33% YoY
As of Mar 2026
Annual Net Income (TTM)
-$160.90M
↑ 8.81% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...